News for Healthier Living
Artesunate Targets GBA To Trigger Apoptosis In Hepatocellular Carcinoma (HCC)
Hepatocellular carcinoma (HCC) remains a highly prevalent malignancy worldwide with limited therapeutic options and frequent resistance to treatment, necessitating the development of targeted pharmacological interventions. Although artesunate, a derivative of the widely used antimalarial drug artemisinin, has emerged as a promising anticancer candidate, the molecular basis underlying its antitumor activity in HCC has remained unclear.
August 18, 2026
August 29 2026August 28 2026August 27 2026August 26 2026August 25 2026August 24 2026August 21 2026August 20 2026August 19 2026August 18 2026August 17 2026August 16 2026August 15 2026
|
|
|
|
|